Position in ARGX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,942,177
-$493,103 QoQ
Shares Held
4,029
-1.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 88.13601389923058.ToString("F0")%
Shared 0.ToString("F0")%
None 11.863986100769422.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ethic Inc. holds $32,626,777 across 32 Biotechnology names. ARGX ranks #3 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,017 | $11,602,734 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,896 | $7,991,279 | |
| 3 | ARGX |
Argenx SE
This page
|
4,029 | $2,942,177 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,869 | $1,280,136 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,998 | $1,252,158 | |
| 6 | INSM |
INSMED Inc
|
6,670 | $1,090,678 | |
| 7 | MRNA |
Moderna, Inc.
|
13,576 | $689,660 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
1,990 | $641,158 |
All Filings in ARGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,942,177 | 4,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $3,435,280 | 4,085 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $825,329 | 1,119 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $552,873 | 1,003 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $697,216 | 1,178 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $756,450 | 1,230 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $298,017 | 693 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $310,811 | 817 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $313,659 | 638 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||